Analyst consensus rating
USANA Health Sciences Analyst Rating: Strong Buy
Direct answer
USANA Health Sciences's consensus rating is Strong Buy.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $25.00.
Forecast evidence checked October 17, 2026.
Get free USANA Health Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $15.54
- Average price target
- $25.00
- High price target
- $25.00
- Low price target
- $25.00
- Low target gap
- +60.9%
- Target upside
- +60.9%
- High target gap
- +60.9%
- Target range width
- 0%
- Consensus rating
- Strong Buy
- Analysts
- 1
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for USANA Health Sciences?
USANA Health Sciences has a verified Strong Buy consensus. The same dataset has an average price target of $25.00.
How far are USANA Health Sciences's low and high targets from the recorded price?
The low target implies +60.9%, while the high target implies +60.9%.
How many analysts are included in USANA Health Sciences's consensus?
The verified consensus includes 1 analysts.
How is USANA Health Sciences's target upside or downside calculated?
The average target of $25.00 is divided by the recorded price of $15.54, then one is subtracted to produce +60.9%. This does not guarantee a future return.
When was USANA Health Sciences's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.